Classification performance of the 2023 ACR/EULAR antiphospholipid syndrome criteria: a systematic review and meta-analysis.

Riancho-Zarrabeitia L, Riancho JA

Open source

DOI
10.1093/rheumatology/keag434
Published
2026 Sep 1
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag434,
  title = {Classification performance of the 2023 ACR/EULAR antiphospholipid syndrome criteria: a systematic review and meta-analysis.},
  author = {Riancho-Zarrabeitia L and Riancho JA},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keag434},
  url = {https://doi.org/10.1093/rheumatology/keag434}
}

RIS

TY  - JOUR
TI  - Classification performance of the 2023 ACR/EULAR antiphospholipid syndrome criteria: a systematic review and meta-analysis.
AU  - Riancho-Zarrabeitia L
AU  - Riancho JA
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keag434
UR  - https://doi.org/10.1093/rheumatology/keag434
ER  - 

APA

L, R., & JA, R. (2026). Classification performance of the 2023 ACR/EULAR antiphospholipid syndrome criteria: a systematic review and meta-analysis.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag434

Source records